http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2021, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 31 Mar 2021 08:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Has+Provided+Initial+Funding+to+NanoSmart+Pharmaceuticals+to+Conduct+Feasibility+Studies+for+Initial+Phases+of+IND-Enabling+Activities/18201545.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Has+Provided+Initial+Funding+to+NanoSmart+Pharmaceuticals+to+Conduct+Feasibility+Studies+for+Initial+Phases+of+IND-Enabling+Activities/18201545.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Has+Provided+Initial+Funding+to+NanoSmart+Pharmaceuticals+to+Conduct+Feasibility+Studies+for+Initial+Phases+of+IND-Enabling+Activities/18201545.html Wed, 31 Mar 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Has+Provided+Initial+Funding+to+NanoSmart+Pharmaceuticals+to+Conduct+Feasibility+Studies+for+Initial+Phases+of+IND-Enabling+Activities/18201545.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Has+Provided+Initial+Funding+to+NanoSmart+Pharmaceuticals+to+Conduct+Feasibility+Studies+for+Initial+Phases+of+IND-Enabling+Activities/18201545.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Has+Provided+Initial+Funding+to+NanoSmart+Pharmaceuticals+to+Conduct+Feasibility+Studies+for+Initial+Phases+of+IND-Enabling+Activities/18201545.html Wed, 31 Mar 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Reveals+Strategic+Plans+for+Company+Growth+and+Focus/18132150.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Reveals+Strategic+Plans+for+Company+Growth+and+Focus/18132150.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Reveals+Strategic+Plans+for+Company+Growth+and+Focus/18132150.html Tue, 16 Mar 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Reveals+Strategic+Plans+for+Company+Growth+and+Focus/18132150.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Reveals+Strategic+Plans+for+Company+Growth+and+Focus/18132150.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Reveals+Strategic+Plans+for+Company+Growth+and+Focus/18132150.html Tue, 16 Mar 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Press+Releases/Oncology+Pharma%2C+Inc.+Vetting+CROs+to+Develop+Research+Plan+and+Indications+for+Recently+Licensed+Cancer+Combination+Therapy/18106242.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma%2C+Inc.+Vetting+CROs+to+Develop+Research+Plan+and+Indications+for+Recently+Licensed+Cancer+Combination+Therapy/18106242.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma%2C+Inc.+Vetting+CROs+to+Develop+Research+Plan+and+Indications+for+Recently+Licensed+Cancer+Combination+Therapy/18106242.html Wed, 10 Mar 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma%2C+Inc.+Vetting+CROs+to+Develop+Research+Plan+and+Indications+for+Recently+Licensed+Cancer+Combination+Therapy/18106242.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma%2C+Inc.+Vetting+CROs+to+Develop+Research+Plan+and+Indications+for+Recently+Licensed+Cancer+Combination+Therapy/18106242.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma%2C+Inc.+Vetting+CROs+to+Develop+Research+Plan+and+Indications+for+Recently+Licensed+Cancer+Combination+Therapy/18106242.html Wed, 10 Mar 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Moves+to+Fund+Lead+Drug+Formulation+%26amp%3B+IND-Enabling+Studies/18079680.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Moves+to+Fund+Lead+Drug+Formulation+%26amp%3B+IND-Enabling+Studies/18079680.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Moves+to+Fund+Lead+Drug+Formulation+%26amp%3B+IND-Enabling+Studies/18079680.html Thu, 04 Mar 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Moves+to+Fund+Lead+Drug+Formulation+%26amp%3B+IND-Enabling+Studies/18079680.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Moves+to+Fund+Lead+Drug+Formulation+%26amp%3B+IND-Enabling+Studies/18079680.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Moves+to+Fund+Lead+Drug+Formulation+%26amp%3B+IND-Enabling+Studies/18079680.html Thu, 04 Mar 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Signs+Worldwide+Licensing+Agreement+with+Sybleu%2C+Inc.+for+Commercialization+of+Chemotherapeutic+Agent+in+Combination+with+a+Bioactive+Immunostimulatory+Agent/18041778.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Signs+Worldwide+Licensing+Agreement+with+Sybleu%2C+Inc.+for+Commercialization+of+Chemotherapeutic+Agent+in+Combination+with+a+Bioactive+Immunostimulatory+Agent/18041778.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Signs+Worldwide+Licensing+Agreement+with+Sybleu%2C+Inc.+for+Commercialization+of+Chemotherapeutic+Agent+in+Combination+with+a+Bioactive+Immunostimulatory+Agent/18041778.html Fri, 26 Feb 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Signs+Worldwide+Licensing+Agreement+with+Sybleu%2C+Inc.+for+Commercialization+of+Chemotherapeutic+Agent+in+Combination+with+a+Bioactive+Immunostimulatory+Agent/18041778.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Signs+Worldwide+Licensing+Agreement+with+Sybleu%2C+Inc.+for+Commercialization+of+Chemotherapeutic+Agent+in+Combination+with+a+Bioactive+Immunostimulatory+Agent/18041778.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Signs+Worldwide+Licensing+Agreement+with+Sybleu%2C+Inc.+for+Commercialization+of+Chemotherapeutic+Agent+in+Combination+with+a+Bioactive+Immunostimulatory+Agent/18041778.html Fri, 26 Feb 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Extends+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Veterinary+Oncology/18008359.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Extends+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Veterinary+Oncology/18008359.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Extends+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Veterinary+Oncology/18008359.html Mon, 22 Feb 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Extends+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Veterinary+Oncology/18008359.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Extends+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Veterinary+Oncology/18008359.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Extends+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Veterinary+Oncology/18008359.html Mon, 22 Feb 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Press+Releases/Oncology+Pharma+is+Pleased+to+Welcome+New+Chairman+to+Its+Scientific+Advisory+Board/17974377.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma+is+Pleased+to+Welcome+New+Chairman+to+Its+Scientific+Advisory+Board/17974377.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma+is+Pleased+to+Welcome+New+Chairman+to+Its+Scientific+Advisory+Board/17974377.html Tue, 16 Feb 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+is+Pleased+to+Welcome+New+Chairman+to+Its+Scientific+Advisory+Board/17974377.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+is+Pleased+to+Welcome+New+Chairman+to+Its+Scientific+Advisory+Board/17974377.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+is+Pleased+to+Welcome+New+Chairman+to+Its+Scientific+Advisory+Board/17974377.html Tue, 16 Feb 2021 08:00:00 -0500 ONPH http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Renews+Licensing+Agreement+With+Ribera+Solutions+LLC+for+Its+Connect2Med+Clinical+Trials+Platform/17935935.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Renews+Licensing+Agreement+With+Ribera+Solutions+LLC+for+Its+Connect2Med+Clinical+Trials+Platform/17935935.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Renews+Licensing+Agreement+With+Ribera+Solutions+LLC+for+Its+Connect2Med+Clinical+Trials+Platform/17935935.html Tue, 09 Feb 2021 08:30:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Renews+Licensing+Agreement+With+Ribera+Solutions+LLC+for+Its+Connect2Med+Clinical+Trials+Platform/17935935.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Renews+Licensing+Agreement+With+Ribera+Solutions+LLC+for+Its+Connect2Med+Clinical+Trials+Platform/17935935.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Renews+Licensing+Agreement+With+Ribera+Solutions+LLC+for+Its+Connect2Med+Clinical+Trials+Platform/17935935.html Tue, 09 Feb 2021 08:30:00 -0500 ONPH http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Extends+Its+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Human+Oncology/17907953.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Extends+Its+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Human+Oncology/17907953.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Extends+Its+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Human+Oncology/17907953.html Wed, 03 Feb 2021 08:30:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Extends+Its+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Human+Oncology/17907953.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Extends+Its+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Human+Oncology/17907953.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Extends+Its+Licensing+Agreement+with+NanoSmart+Pharmaceuticals%2C+Inc.+for+Human+Oncology/17907953.html Wed, 03 Feb 2021 08:30:00 -0500 ONPH http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Announces+the+Appointment+Of+New+Chief+Financial+Officer/17882317.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Announces+the+Appointment+Of+New+Chief+Financial+Officer/17882317.html for the full story. http://www.streetinsider.com/Press+Releases/Oncology+Pharma+Announces+the+Appointment+Of+New+Chief+Financial+Officer/17882317.html Thu, 28 Jan 2021 18:25:00 -0500 ONPH http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Announces+the+Appointment+Of+New+Chief+Financial+Officer/17882317.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Announces+the+Appointment+Of+New+Chief+Financial+Officer/17882317.html for the full story. http://www.streetinsider.com/Globe+Newswire/Oncology+Pharma+Announces+the+Appointment+Of+New+Chief+Financial+Officer/17882317.html Thu, 28 Jan 2021 18:25:00 -0500 ONPH